Breast Cancer and Tamoxifen: A Nigerian Perspective to Effective Personalised Therapy

Estrogen-receptor positivity in tumour, often requiring long-term tamoxifen therapy, is thought to characterise between 43% and 65% of breast cancer cases in Nigeria. The patient population is further marked by late-stage diagnosis which significantly heightens the tendency for tumour relapse in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Adehin, Ayorinde, Kennedy, Martin Alexander, Soyinka, Julius Olugbenga, Alatise, Olusegun Isaac, Olasehinde, Olalekan, Bolaji, Oluseye Oladotun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548221/
https://www.ncbi.nlm.nih.gov/pubmed/33116814
http://dx.doi.org/10.2147/BCTT.S266314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548221/
https://www.ncbi.nlm.nih.gov/pubmed/33116814
http://dx.doi.org/10.2147/BCTT.S266314

Ejemplares similares